John E Battersby

Title: John E Battersby: Innovator in Pharmaceutical Composition

Introduction

John E Battersby is a notable inventor based in Hillsborough, CA (US), recognized for his contributions to the field of pharmaceuticals. With a total of 2 patents, he has made significant strides in developing innovative solutions for sustained drug release.

Latest Patents

Battersby's latest patents include a "Sustained release pharmaceutical composition" and a "Process for preparing storage stable pharmaceuticals." The first patent discloses the formation of imine adducts, particularly between a primary amine of a biologically active polypeptide and a reactive aldehyde group of a physiologically acceptable carrier. This technology allows for the controlled release of biologically active polypeptides, such as human growth hormone, over a predetermined period. The second patent focuses on container systems designed to prevent the formation of adducts between pharmaceutical compounds and aldehydes during storage, ensuring the stability of these compounds.

Career Highlights

Battersby is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work has contributed to advancements in pharmaceutical formulations that enhance the efficacy and stability of medications.

Collaborations

Throughout his career, Battersby has collaborated with esteemed colleagues, including William S Hancock and Ross G Clark, further enriching his research and development efforts.

Conclusion

John E Battersby stands out as a significant figure in the pharmaceutical industry, with his innovative patents paving the way for improved drug delivery systems. His work continues to impact the field positively, demonstrating the importance of innovation in healthcare.